Catalyst Wire Dossier Catalyst Wire Dossier

Genetically corrected autologous epidermal grafts (skin equivalents)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genetically corrected autologous epidermal grafts (skin equivalents), covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts [Phase 1, Phase 2]

See pricing